Celyad to Host Conference Call to Review Clinical Update from ESMO 21st World GI Congress
MONT-SAINT-GUIBERT, Belgium, July 02, 2019 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that Professor Dr. …